|

CYB003 Clinical Trials

3 actively recruiting trials across 3 locations

▲ +1 trial since July 2026

Pipeline

Phase 2: 1Phase 3: 2

Top Sponsors

  • Cybin IRL Limited2
  • Ohio State University1

Indications

  • Depression3
  • Major Depressive Disorder2
  • Depression Disorder1
  • Major Depressive Disorder (MDD)1
  • Depression Disorders1

Birmingham, Alabama1 trial

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

UAB Psychiatry and Behavioral Neurology

Phase 3

Phoenix, Arizona1 trial

"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"

Scottsdale Research Institute

Phase 3

Columbus, Ohio1 trial

A Mechanistic Study to Assess a Single Dose of CYB003 in Participants With Depression and Anxiety

The Ohio State University Department of Psychiatry

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.